Cargando…

Retinal capillary rarefaction is associated with arterial and kidney damage in hypertension

Microvascular disease and rarefaction are key pathological hallmarks of hypertension. The retina uniquely allows direct, non-invasive investigation of the microvasculature. Recently developed optical coherence tomography angiography now allows investigation of the fine retinal capillaries, which may...

Descripción completa

Detalles Bibliográficos
Autores principales:	Frost, Shaun, Nolde, Janis Marc, Chan, Justine, Joyson, Anu, Gregory, Cynthia, Carnagarin, Revathy, Herat, Lakshini Y., Matthews, Vance B., Robinson, Liam, Vignarajan, Janardhan, Prentice, David, Kanagasingam, Yogesan, Schlaich, Markus P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7806760/ https://www.ncbi.nlm.nih.gov/pubmed/33441624 http://dx.doi.org/10.1038/s41598-020-79594-3

Ejemplares similares

Microvascular changes at different stages of chronic kidney disease
por: Kannenkeril, Dennis, et al.
Publicado: (2020)

Supine blood pressure—A clinically relevant determinant of vascular target organ damage in hypertensive patients
por: Nolde, Janis M., et al.
Publicado: (2020)

Focusing on Sodium Glucose Cotransporter-2 and the Sympathetic Nervous System: Potential Impact in Diabetic Retinopathy
por: Herat, Lakshini Y., et al.
Publicado: (2018)

Current Knowledge of IL-6 Cytokine Family Members in Acute and Chronic Kidney Disease
por: Magno, Aaron L., et al.
Publicado: (2019)

Combined renal and common hepatic artery denervation as a novel approach to reduce cardiometabolic risk: technical approach, feasibility and safety in a pre-clinical model
por: Kiuchi, Márcio Galindo, et al.
Publicado: (2021)

The Schlager mouse as a model of altered retinal phenotype
por: Herat, Lakshini Y., et al.
Publicado: (2019)

Renal denervation as a synergistic tool for the treatment of polymorphic ventricular ectopic beats: A case report
por: Kiuchi, Márcio Galindo, et al.
Publicado: (2020)

The Impact of SGLT2 Inhibitors in the Heart and Kidneys Regardless of Diabetes Status
por: Matthews, Jennifer, et al.
Publicado: (2023)

Circulating platelet‐derived extracellular vesicles correlate with night‐time blood pressure and vascular organ damage and may represent an integrative biomarker of vascular health
por: Lugo‐Gavidia, Leslie Marisol, et al.
Publicado: (2022)

Association of Circulating Platelet Extracellular Vesicles and Pulse Wave Velocity with Cardiovascular Risk Estimation
por: Lugo-Gavidia, Leslie Marisol, et al.
Publicado: (2022)

Implications of ADAM17 activation for hyperglycaemia, obesity and type 2 diabetes
por: Matthews, Jennifer, et al.
Publicado: (2021)

The Sympathetic Nervous System Regulates Sodium Glucose Co-Transporter 1 Expression in the Kidney
por: Matthews, Jennifer, et al.
Publicado: (2023)

Sympathetic stimulation with norepinephrine may come at a cost
por: Herat, Lakshini Y., et al.
Publicado: (2019)

Sympathetic Activation in Hypertensive Chronic Kidney Disease – A Stimulus for Cardiac Arrhythmias and Sudden Cardiac Death?
por: Kiuchi, Márcio Galindo, et al.
Publicado: (2020)

Homocysteine predicts vascular target organ damage in hypertension and may serve as guidance for first‐line antihypertensive therapy
por: Carnagarin, Revathy, et al.
Publicado: (2021)

Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)—A Condition Associated with Heightened Sympathetic Activation
por: Carnagarin, Revathy, et al.
Publicado: (2021)

Evaluation of Artificial Intelligence–Based Grading of Diabetic Retinopathy in Primary Care
por: Kanagasingam, Yogesan, et al.
Publicado: (2018)

SGLT2 Inhibitor–Induced Sympathoinhibition: A Novel Mechanism for Cardiorenal Protection
por: Herat, Lakshini Y., et al.
Publicado: (2020)

Determining the role of SGLT2 inhibition with Empagliflozin in the development of diabetic retinopathy
por: Matthews, Jennifer, et al.
Publicado: (2022)

Targeting Features of the Metabolic Syndrome Through Sympatholytic Effects of SGLT2 Inhibition
por: Herat, Lakshini Y., et al.
Publicado: (2022)

The Metalloproteinase ADAM28 Promotes Metabolic Dysfunction in Mice
por: Herat, Lakshini, et al.
Publicado: (2017)

The molecular basis for the neutral effect of renal denervation in patients with chronic heart failure not responding to cardiac resynchronisation therapy – a perspective
por: Kiuchi, Márcio Galindo, et al.
Publicado: (2019)

Multi-organ denervation: a novel approach to combat cardiometabolic disease
por: Kiuchi, Márcio Galindo, et al.
Publicado: (2023)

New Approaches in the Management of Sudden Cardiac Death in Patients with Heart Failure—Targeting the Sympathetic Nervous System
por: Kiuchi, Márcio Galindo, et al.
Publicado: (2019)

The Effect of SGLT2 Inhibition on Diabetic Kidney Disease in a Model of Diabetic Retinopathy
por: Matthews, Jennifer Rose, et al.
Publicado: (2022)

SGLT2 Inhibitor-Induced Sympathoexcitation in White Adipose Tissue: A Novel Mechanism for Beiging
por: Matthews, Jennifer R., et al.
Publicado: (2020)

SGLT1/2 inhibition improves glycemic control and multi-organ protection in type 1 diabetes
por: Herat, Lakshini Yasaswi, et al.
Publicado: (2023)

Female Gender Is Associated with Higher Susceptibility of Weight Induced Arterial Stiffening and Rise in Blood Pressure
por: Zuo, Junli, et al.
Publicado: (2021)

Machine learning powered tools for automated analysis of muscle sympathetic nerve activity recordings
por: Nolde, Janis M., et al.
Publicado: (2021)

Capillary rarefaction from the kidney point of view
por: Afsar, Baris, et al.
Publicado: (2018)

Sympathetic Nervous System Activation and Its Modulation: Role in Atrial Fibrillation
por: Carnagarin, Revathy, et al.
Publicado: (2019)

Teledentistry as a novel pathway to improve dental health in school children: a research protocol for a randomised controlled trial
por: Estai, Mohamed, et al.
Publicado: (2020)

The Influence of Hypertensive Therapies on Circulating Factors: Clinical Implications for SCFAs, FGF21, TNFSF14 and TNF-α
por: Magno, Aaron L., et al.
Publicado: (2020)

Treatment of Essential Hypertension does not Normalize Capillary Rarefaction
por: de Araújo Penna, Guilherme Loures, et al.
Publicado: (2008)

Prazosin Can Prevent Glucocorticoid Mediated Capillary Rarefaction
por: Mandel, Erin R., et al.
Publicado: (2016)

Peritubular Capillary Rarefaction: An Underappreciated Regulator of CKD Progression
por: Kida, Yujiro
Publicado: (2020)

A fast and fully automated system for glaucoma detection using color fundus photographs
por: Saha, Sajib, et al.
Publicado: (2023)

TNFSF14-Derived Molecules as a Novel Treatment for Obesity and Type 2 Diabetes
por: Agostino, Mark, et al.
Publicado: (2021)

Capillary rarefaction, hypoxia, VEGF and angiogenesis in chronic renal disease
por: Mayer, Gert
Publicado: (2011)

Retinal Capillary Rarefaction in Patients with Type 2 Diabetes Mellitus
por: Jumar, Agnes, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_iitejftg3j09b3s455b0ajfl83